Structure-activity relationships of anti-HIV-1 N-alkoxy- and N-allyloxy-benzimidazoles.

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 4, 1997, Pages 409-412

  Evans, Tahnee M ^a   Gardiner, John M ^a   Mahmood, Naheed ^b   Smis, Marilyne ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; STRUCTURE ACTIVITY RELATION;

EID: 0031576815     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00022-X     Document Type: Article

References (18)

1. [1]. (a) De Clercq, E. Med. Res. Rev. 1993, 13, 229.
2. Young, S. D. Persp. Drug. Disc. Des. 1993, 1, 181.
3. [2]. Pauwels, R.; Andries, K.; Desmyter, J.; Schols, D.; Kukla, M.J.; Breslin, H.; Raeymaeckers, A.; Van Gelder, J.; Woestenborghs, R.; Heykants, J.; Schellekens, K.; Janssen, M. A. C.; De Clercq, E.; Janssen, P. A. J. Nature 1990, 343, 470.
4. [3]. Hoffman, J. M.; Smith, A. M.; Rooney, C. S.; Fisher, T. E.; Wai, J. S.; Thomas, C. M.; Bamberger, D. L.; Barnes, J. L.; Williams, T.M.; Jones, J.H.; Olson, B.D.; O'Brien, J.A.; Goldman, M.E.; Nunberg, J.H.; Qunitero, J.C.; Schleif, W.A.; Emini, E.A.; Anderson, P.S. J. Med. Chem. 1993, 56, 953.
5. [4]. Romero, D. L.; Busso, M.; Tan, C.-K.; Reusser, F.; Palmer, J. R.; Poppe, S. M.; Aristoff, P. A.; Downey, K. M.; So, A. G.; Resnick, L.; Tarpley, W. G. Proc. Natl. Acad. Sci. USA 1991, 88, 8806.
6. [5]. (a) Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasaka, T. J. Med. Chem. 1992, 35, 337.
7. (b) Baba, M.; Tanaka, H.; Miyasaka, T.; Yuasa, S.; Ubasawa, M.; Walker, R. T.; Declercq, E. Nucleosides and Nucleotides 1995, 14, 575.
8. [6]. Baba, M.; De Clercq, E.; Tanaka, H.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Umezu, K.; Nakashima, H.; Mori, S.; Shigeta, S.; Walker, R. T.; Miyasaka, T. Proc. Natl. Acad. Sci. USA 1991, 88, 2356.
9. [7]. (a) Hargrave, K. D.; Proudfoot, J. R.; Grozinger, K. G.; Cullen, E.; Kapadia, S. R.; Patel, U. R.; Fuchs, V. U.; Mauldin, S. C.; Vitous, J.; Behnke, M. L.; Klunder, J. M.; Pal, K.; Skiles, J. W.; McNeil, D. W.; Rose, J. M.; Chow, G. C.; Skoog, M. T.; Wu, J. C.; Schmidt, G.; Engel, W. W.; Eberlein, W. G.; Saboe, T. D.; Campbell, S.J.; Rosenthal, A. S.; Adams, J. J. Med. Chem. 1991, 34, 2231.
10. (b) Proudfoot, J. R.; Patel, U. R.; Kapadia, S. R.; Hargrave, K. D. J. Med. Chem. 1995, 38, 1406.
11. [8]. (a) Ren, J.; Esnouf, R.; Garman, E.; Somers, D.; Ross, C.; Kirby, I.; Keeling, J.; Darby, G.; Jones, Y.; Stuart, D.; Stammers, D. Nature Struct. Biol. 1995, 2, 293.
12. (b) Esnouf, R.; Ren, J.; Ross, C.; Jones, Y.; Stammers, D.; Stuart, D. Nature Struct. Biol. 1995, 2, 303.
13. (c) Ding, J.; Das, K.; Moereels, H.; Koymans, L.; Andreis, K.; Janssen, P. A. J.; Hughes, S. H.; Arnold, E. Nature Struct. Biol. 1995, 2, 407.
14. [9]. Mellors, J. W.; Im, G.-J.; Tramontane, E.; Winkler, S. R.; Medina, D. J.; Dutschman, G. E.; Bazmi, H. Z.; Piras, G.; Gonzalez, C. J.; Cheng, Y.-C. Mol. Pharmacol. 1993, 43, 11.
15. [10]. Kleim, J. P.; Bender, R.; Billhardt, U.-M.; Meichsner, C.; Reiss, G.; Rosner, M.; Winkler, I.; Paessens, A. Antimicrob. Agents & Chemother. 1993, 37, 1659.
16. [11]. Gardiner, J. M.; Loyns, C. R.; Burke, A.; Khan, A.; Mahmood, N. Bioorg. Med. Chem. Letts. 1995, 5, 1251.
17. [12]. Gardiner, J. M.; Loyns, C. R.; Schwalbe, C. H.; Barrett, G. C.; Lowe, P. R. Tetrahedron 1995, 51, 4101.
18. [13]. Cytotoxicities were determined using the C8166 cell line. Data for infected and uninfected cells are based on 3-5 determinations per compound. Assay mthodology is described in reference 11.